Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-04-24

Clinical Trial Update: Neurobiology of Treatment Responses in MDD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 3 | Status: WITHDRAWN